[
  {
    "ts": "2025-10-27T19:06:00+00:00",
    "headline": "Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025",
    "summary": "SAN FRANCISCO, October 27, 2025--Edwards Lifesciences (NYSE: EW) today announced data demonstrating successful patient outcomes supporting its portfolio of mitral and tricuspid therapies. One-year data from the ENCIRCLE single-arm pivotal trial achieved all primary and secondary endpoints for safety and effectiveness, with outcomes simultaneously published in The Lancet. Thirty-day data from the EVOQUE system STS/ACC TVT Registry, the largest real-world transcatheter tricuspid valve replacement",
    "url": "https://finance.yahoo.com/news/successful-patient-outcomes-demonstrated-edwards-190600679.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "0aad3d54-2aa3-39dd-87c6-114129091e45",
      "content": {
        "id": "0aad3d54-2aa3-39dd-87c6-114129091e45",
        "contentType": "STORY",
        "title": "Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025",
        "description": "",
        "summary": "SAN FRANCISCO, October 27, 2025--Edwards Lifesciences (NYSE: EW) today announced data demonstrating successful patient outcomes supporting its portfolio of mitral and tricuspid therapies. One-year data from the ENCIRCLE single-arm pivotal trial achieved all primary and secondary endpoints for safety and effectiveness, with outcomes simultaneously published in The Lancet. Thirty-day data from the EVOQUE system STS/ACC TVT Registry, the largest real-world transcatheter tricuspid valve replacement",
        "pubDate": "2025-10-27T19:06:00Z",
        "displayTime": "2025-10-27T19:06:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/d73d6311c458c80902a7a32da4210b25",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/is6MC.9qk17m4wzKAEoRFQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/d73d6311c458c80902a7a32da4210b25.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gsjrBvM5tnWrxJB.SMRqyA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d73d6311c458c80902a7a32da4210b25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/successful-patient-outcomes-demonstrated-edwards-190600679.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/successful-patient-outcomes-demonstrated-edwards-190600679.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T18:22:00+00:00",
    "headline": "Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025",
    "summary": "SAN FRANCISCO, October 27, 2025--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical outcomes at one year, also demonstrate excellent long-term valve performance and durability. Separately, 10-year results from PARTNER 2 intermediate risk studies reinforce Edwards’ leadership in setting the standard for lasting valve performance and excellent patien",
    "url": "https://finance.yahoo.com/news/edwards-sapien-3-tavr-delivers-182200671.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "e7bd5e3a-fac2-3058-96f4-45ad86211a01",
      "content": {
        "id": "e7bd5e3a-fac2-3058-96f4-45ad86211a01",
        "contentType": "STORY",
        "title": "Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025",
        "description": "",
        "summary": "SAN FRANCISCO, October 27, 2025--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data, which showed superior clinical outcomes at one year, also demonstrate excellent long-term valve performance and durability. Separately, 10-year results from PARTNER 2 intermediate risk studies reinforce Edwards’ leadership in setting the standard for lasting valve performance and excellent patien",
        "pubDate": "2025-10-27T18:22:00Z",
        "displayTime": "2025-10-27T18:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/903a33324ad5315ad0020ff58723fe15",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wV_T84AU4Rnuairk3QB.Ew--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/903a33324ad5315ad0020ff58723fe15.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vmrRtTC8C2ISFP4SsA945g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/903a33324ad5315ad0020ff58723fe15.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/edwards-sapien-3-tavr-delivers-182200671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/edwards-sapien-3-tavr-delivers-182200671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T14:00:16+00:00",
    "headline": "Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "summary": "Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finance.yahoo.com/news/idexx-laboratories-idxx-earnings-expected-140016635.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "011e9888-53aa-3fdc-aa64-5bc8a59b2131",
      "content": {
        "id": "011e9888-53aa-3fdc-aa64-5bc8a59b2131",
        "contentType": "STORY",
        "title": "Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
        "description": "",
        "summary": "Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
        "pubDate": "2025-10-27T14:00:16Z",
        "displayTime": "2025-10-27T14:00:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SVlgtyKcqJmTvHzvwqjZfA--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7KqPU5XU5bEHAxdnZQ3L5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/idexx-laboratories-idxx-earnings-expected-140016635.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/idexx-laboratories-idxx-earnings-expected-140016635.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDXX"
            },
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-27T12:30:00+00:00",
    "headline": "Cardiovascular Repair & Reconstruction Devices - Global Market Forecast (2025-2032) Featuring Profiles of Medtronic, Edwards Lifesciences, Abbott Labs, Boston Scientific, Terumo and More",
    "summary": "The cardiovascular repair market is fueled by an aging population, technological advancements, and the rise in comorbidities. Opportunities lie in innovative, minimally invasive devices, value-based contracting, and regional market dynamics. Emphasizing personalized, data-driven solutions and supply chain resilience is crucial for growth. Cardiovascular Repair & Reconstruction Devices Market Cardiovascular Repair & Reconstruction Devices Market Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The \"Card",
    "url": "https://finance.yahoo.com/news/cardiovascular-repair-reconstruction-devices-global-123000822.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "74fceacf-bf76-3196-954c-dca6471c5323",
      "content": {
        "id": "74fceacf-bf76-3196-954c-dca6471c5323",
        "contentType": "STORY",
        "title": "Cardiovascular Repair & Reconstruction Devices - Global Market Forecast (2025-2032) Featuring Profiles of Medtronic, Edwards Lifesciences, Abbott Labs, Boston Scientific, Terumo and More",
        "description": "",
        "summary": "The cardiovascular repair market is fueled by an aging population, technological advancements, and the rise in comorbidities. Opportunities lie in innovative, minimally invasive devices, value-based contracting, and regional market dynamics. Emphasizing personalized, data-driven solutions and supply chain resilience is crucial for growth. Cardiovascular Repair & Reconstruction Devices Market Cardiovascular Repair & Reconstruction Devices Market Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The \"Card",
        "pubDate": "2025-10-27T12:30:00Z",
        "displayTime": "2025-10-27T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/ef9b79c41af4d92ca23562065e65e56a",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Cardiovascular Repair & Reconstruction Devices Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9Pi3Os16Lygr_v.FL64zRw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/ef9b79c41af4d92ca23562065e65e56a.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2kGFqli9nz6PKmPCKUBV_Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/ef9b79c41af4d92ca23562065e65e56a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cardiovascular-repair-reconstruction-devices-global-123000822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cardiovascular-repair-reconstruction-devices-global-123000822.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "EW"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "4543.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]